Skip to content
UniqueBaseENFor AI ↗
Companies

MEDVi

GLP-1 weight-loss telemedicine and online consultations.

Visit website ↗

Overview

AI-powered telemedicine platform focused on online consultations and delivery of prescription GLP-1 weight-loss medication, operated by a very lean team using AI tools.

Funding

USD estimates from the source record

No funding records are listed yet.

Annual trendUnit: USD estimate

No chartable funding estimates yet.

No funding rows to list.

Valuation

USD estimates from the source record

No valuation records are listed yet.

Annual trendUnit: USD estimate

No chartable valuation estimates yet.

No valuation rows to list.

Revenue

USD estimates from the source record

Listed 2 revenue records. Latest revenue: $1.8B, Apr 2, 2026.

Annual trendUnit: USD estimate
20252026$1.8BDec 5, 2025: $401MApr 2, 2026: $1.8B
Revenue dateAmountSource
Apr 2, 2026$1.8BSource ↗
Dec 5, 2025$401MSource ↗

Team, products & investors

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

GLP-1减重远程医疗在线问诊 AI 驱动的远程医疗平台,主打 GLP-1 减重处方药在线问诊与配送,以极精简团队和 AI 工具运营。